Plavix, Clopidogrel News

“Obviously, generic competition would be a most unwelcome development”

French drugmaker Sanofi-Aventis , which briefly encountered generic competition to its second-biggest product Plavix in the United States in 2006 and 2007, now faces a similar threat in Europe. via BNET

Comment?

Many people know that the Federal Reserve sets interest rates in order to loan money to other banks so they can keep cash flowing throughout the U.S. financial system. via Fox News

Comment?

“While it is important for patients to stay on clopidogrel to prevent the progression of coronary heart disease, ulcers and bleeding can result in patients not taking their heart disease medicine.”

Main Category: GastroIntestinal / Gastroenterology Also Included In: Conferences ; Pharma Industry / Biotech Industry Article Date: 07 May 2008 - 0:00 PDT A review of medical claims from more than 70 managed ... via Medical News Today

Comment?

The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events Jeff S. Healey, MD, MSc ; Robert G. Hart, MD ; Janice Pogue, MSc ; Marc A. Pfeffer, MD, PhD ; Stefan H. Hohnloser, MD ... via Circulation

Comment?

Graeme J. Hankey, MD, FRACP John W. Eikelboom, MB, BS, MSc From McMaster University , Hamilton, ON, Canada; and the School of Medicine and Pharmacology , University of Western Australia, Perth, Australia. via Circulation

Comment?

Mark J. Alberts, MD, FAHA ; Oscar Benavente, MD ; Karen Furie, MD, MPH, FAHA ; Larry B. Goldstein, MD, FAHA, FAAN ; Philip Gorelick, MD, MPH, FAHA, FAAN ; Jonathan Halperin, MD, FAHA ; Robert Harbaugh, MD, ... via Circulation

Comment?

“Dr. Reddy's would be able to commence marketing almost immediately in the event of a CAFC decision of invalidity, while Apotex would remain bound by injunction until the mandate issues.”

BMY / RDY / TEVA In November 2001, Apotex became the first company to file an ANDA for a generic version of Plavix with a paragraph IV certification. via The Biotech Stock Blog

Comment?

“On June 11, 2007, BMS agreed to plead guilty and pay a $1 million criminal fine for misleading the government about the Plavix patent deal.”

Corporations reaching deferred or non-prosecution agreements with the government, often find themselves paying money and offering cooperation in return for an agreement that will allow the company to continue ... via White Collar Crime Prof Blog

Comment?

“The Department of Justice will vigorously prosecute such illegal activity.”

The Department of Justice announced today that the former senior vice president of Bristol-Myers Squibb Company , Andrew Bodnar, was indicted for his role in lying to the federal government about a patent deal ... via Federal Bureau of Investigation

Comment?

Adding a glycoprotein IIb/IIIa inhibitor to a high loading dose of clopidogrel in patients with acute ST-elevated myocardial infarction undergoing percutaneous coronary intervention does not further improve ... via CMA.ca

Comment?